News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.

1Bitget UEX Daily | Hopes for Middle East Peace Rise; Nasdaq Sets Record 12-Day Winning Streak; Anthropic Releases New AI Model (April 17, 2026)2TSMC 2026 Q1 Earnings Highlights: Record Net Profit Soars 58%, AI-Driven Revenue Jumps 35%, Strong Q2 Guidance3Netflix Q1 2026 Earnings Highlights: 16% Revenue Growth Beats Expectations, EPS Surges 86%, But Soft Q2 Guidance Triggers ~10% After-Hours Drop


USD: Range trade view holds – BBH
101 finance·2026/04/17 13:36
USD/JPY declines after Hormuz resumes operations, risk sentiment impacts US Dollar
101 finance·2026/04/17 13:30


Super Week Arrives: Global Market Outlook Amid Policy Shifts and Dense Data
汇通财经·2026/04/17 13:14
Fed: Nordea raises doubts about rate reductions amid rising inflation concerns
101 finance·2026/04/17 12:39
Flash
15:22
Staking service provider P2P.org appoints former Citigroup executive Betsabe Botaitis as CFOForesight News reports that, according to Fortune magazine, institutional crypto staking infrastructure provider P2P.org has announced the appointment of Betsabe Botaitis as its new Chief Financial Officer. Betsabe Botaitis previously worked at Citigroup and LendingClub, and has many years of experience in financial data strategy and AI applications. Founded in 2018, P2P.org provides banks, exchanges, digital wallets, and custodians with validator, server, and security system support for more than 40 blockchain networks including Ethereum and Solana, assisting institutional clients in earning staking rewards without the need to build their own systems.
15:15
Trump: Iran Agrees to 'Everything' On April 17, Trump told NewsNation that Iran has agreed to 'everything.' Iran has agreed not to close the Strait of Hormuz again, which will no longer be used as a weapon against the world. Iran has also agreed to stop enriching uranium. As of the time of publication, crude oil prices had dropped over 12%, and European gas prices fell by 10% following President Trump's remarks about the Strait of Hormuz.
15:15
Kidney cancer drug data update shows improvement, Kura stock risesPreviously, the company released preliminary subgroup analysis data on the combination treatment of darlifarnib and cabozantinib for patients with clear cell renal cell carcinoma (ccRCC) who had previously been treated with cabozantinib. According to a statement, the relevant results are from the ongoing FIT-001 clinical trial: Subgroup analysis data on patients previously treated with cabozantinib supported the potential of this therapy to overcome resistance. Tumor reduction was observed in 75% of patients. Across multiple dose levels, all renal cell carcinoma (RCC) patients demonstrated manageable safety and tolerability characteristics.
News